Diagnostic Testing & Technology Report

The FDA has formed an internal FDA Nanotechnology Task Force, which is charged with determining regulatory approaches that encourage the development of safe and effective FDA-regulated products that use nanotechnology materials. The task force will recommend ways to identify and address gaps in knowledge or policy related to nanotechnology, particularly the potentially adverse health effects from these products.